
<?phpxml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
>
<channel>
<title>World Pharma News / Published News / Corporate</title>
<link>http://www.worldpharmanews.net</link>
<description>World Pharma News .net - Web 2.0 pharmaceutical news portal  votes</description>
<pubDate>Tue, 26 Jan 2010 00:42:46 EET</pubDate>
<language>en</language>
<item>
<title><![CDATA[Bristol-Myers Squibb supporting efforts to help survivors]]></title>
<link>http://www.worldpharmanews.net/Corporate/Bristol-Myers_Squibb_supporting_efforts_to_help_survivors/</link>
<comments>http://www.worldpharmanews.net/Corporate/Bristol-Myers_Squibb_supporting_efforts_to_help_survivors/</comments>
<pubDate>Tue, 26 Jan 2010 00:42:46 EET</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Bristol-Myers_Squibb_supporting_efforts_to_help_survivors/</guid>
<description><![CDATA[Bristol-Myers Squibb is joining the world community in providing immediate help for survivors of the massive earthquake that struck Haiti on January 12. The company has already shipped a large donati<br/><br/>3 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Sanofi-aventis and employees unite for the victims of Haiti]]></title>
<link>http://www.worldpharmanews.net/Corporate/Sanofi-aventis_and_employees_unite_for_the_victims_of_Haiti/</link>
<comments>http://www.worldpharmanews.net/Corporate/Sanofi-aventis_and_employees_unite_for_the_victims_of_Haiti/</comments>
<pubDate>Mon, 25 Jan 2010 00:03:15 EET</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Sanofi-aventis_and_employees_unite_for_the_victims_of_Haiti/</guid>
<description><![CDATA[In the face of the unprecedented earthquake that hit the island of Haiti, sanofi-aventis has committed 1 million Euros in financial aid to long-term reconstruction initiatives and the rehabilitation <br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Pfizer Extends Commitment to Help Unemployed Americans]]></title>
<link>http://www.worldpharmanews.net/Corporate/Pfizer_Extends_Commitment_to_Help_Unemployed_Americans/</link>
<comments>http://www.worldpharmanews.net/Corporate/Pfizer_Extends_Commitment_to_Help_Unemployed_Americans/</comments>
<pubDate>Wed, 16 Dec 2009 01:32:43 EET</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Pfizer_Extends_Commitment_to_Help_Unemployed_Americans/</guid>
<description><![CDATA[Pfizer will extend its MAINTAIN™ (Medicines Assistance for Those who Are in Need) patient assistance program for an additional year, through December 31, 2010. In addition to the more than 70 Pfizer <br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[GSK and Intercell form strategic alliance to develop and commercialise innovative vaccines]]></title>
<link>http://www.worldpharmanews.net/Corporate/GSK_and_Intercell_form_strategic_alliance_to_develop_and_commercialise_innovative_vaccines/</link>
<comments>http://www.worldpharmanews.net/Corporate/GSK_and_Intercell_form_strategic_alliance_to_develop_and_commercialise_innovative_vaccines/</comments>
<pubDate>Wed, 16 Dec 2009 01:32:22 EET</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/GSK_and_Intercell_form_strategic_alliance_to_develop_and_commercialise_innovative_vaccines/</guid>
<description><![CDATA[GlaxoSmithKline Biologicals SA (GSK) and Intercell announced an agreement to form a strategic alliance to accelerate the development and commercialisation of needle-free, patch-based vaccines. The ag<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems]]></title>
<link>http://www.worldpharmanews.net/Corporate/Abbott_to_Acquire_STARLIMS_Technologies_Ltd-_a_Leader_in_Laboratory_Information_Management_Systems/</link>
<comments>http://www.worldpharmanews.net/Corporate/Abbott_to_Acquire_STARLIMS_Technologies_Ltd-_a_Leader_in_Laboratory_Information_Management_Systems/</comments>
<pubDate>Tue, 15 Dec 2009 01:45:38 EET</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Abbott_to_Acquire_STARLIMS_Technologies_Ltd-_a_Leader_in_Laboratory_Information_Management_Systems/</guid>
<description><![CDATA[Abbott (NYSE: ABT) announced today a definitive agreement to acquire STARLIMS Technologies Ltd. (Nasdaq: LIMS), a leading provider of laboratory information management systems, for approximately $123<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Sanofi-aventis enters into an Exclusive Global Licensing Agreement with The Rockefeller University]]></title>
<link>http://www.worldpharmanews.net/Corporate/Sanofi-aventis_enters_into_an_Exclusive_Global_Licensing_Agreement_with_The_Rockefeller_University/</link>
<comments>http://www.worldpharmanews.net/Corporate/Sanofi-aventis_enters_into_an_Exclusive_Global_Licensing_Agreement_with_The_Rockefeller_University/</comments>
<pubDate>Tue, 08 Dec 2009 01:40:34 EET</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Sanofi-aventis_enters_into_an_Exclusive_Global_Licensing_Agreement_with_The_Rockefeller_University/</guid>
<description><![CDATA[Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced an exclusive global licensing agreement with The Rockefeller University (New York, NY) concerning a novel monoclonal antibody, targeting certain<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[AstraZeneca and Targacept Form Global Collaboration and Licence Agreement]]></title>
<link>http://www.worldpharmanews.net/Corporate/AstraZeneca_and_Targacept_Form_Global_Collaboration_and_Licence_Agreement/</link>
<comments>http://www.worldpharmanews.net/Corporate/AstraZeneca_and_Targacept_Form_Global_Collaboration_and_Licence_Agreement/</comments>
<pubDate>Sun, 06 Dec 2009 15:06:53 EET</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/AstraZeneca_and_Targacept_Form_Global_Collaboration_and_Licence_Agreement/</guid>
<description><![CDATA[AstraZeneca and Targacept, Inc. announced a collaboration and licence agreement for the global development and commercialisation of TC-5214, Targacept's late-stage investigational product for major <br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Novartis gains rights to two oral targeted investigational therapies]]></title>
<link>http://www.worldpharmanews.net/Corporate/Novartis_gains_rights_to_two_oral_targeted_investigational_therapies/</link>
<comments>http://www.worldpharmanews.net/Corporate/Novartis_gains_rights_to_two_oral_targeted_investigational_therapies/</comments>
<pubDate>Fri, 04 Dec 2009 01:34:38 EET</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Novartis_gains_rights_to_two_oral_targeted_investigational_therapies/</guid>
<description><![CDATA[Novartis has gained exclusive rights to two oral targeted investigational therapies for patients with a range of life-threatening blood disorders and cancers that currently do not have effective trea<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility]]></title>
<link>http://www.worldpharmanews.net/Corporate/Novartis_inaugurates_large-scale_US_based_cell-culture_influenza_vaccine_manufacturing_facility/</link>
<comments>http://www.worldpharmanews.net/Corporate/Novartis_inaugurates_large-scale_US_based_cell-culture_influenza_vaccine_manufacturing_facility/</comments>
<pubDate>Sat, 28 Nov 2009 20:07:38 EET</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Novartis_inaugurates_large-scale_US_based_cell-culture_influenza_vaccine_manufacturing_facility/</guid>
<description><![CDATA[Today, Novartis officially inaugurated the US's first ever large-scale flu cell culture vaccine and adjuvant manufacturing facility in Holly Springs, North Carolina. The facility is a result of a pa<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Merck KGaA to Expand Research and Development Presence in China]]></title>
<link>http://www.worldpharmanews.net/Corporate/Merck_KGaA_to_Expand_Research_and_Development_Presence_in_China/</link>
<comments>http://www.worldpharmanews.net/Corporate/Merck_KGaA_to_Expand_Research_and_Development_Presence_in_China/</comments>
<pubDate>Thu, 26 Nov 2009 00:33:37 EET</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Merck_KGaA_to_Expand_Research_and_Development_Presence_in_China/</guid>
<description><![CDATA[Merck KGaA announced plans to strengthen its global research and development (R&amp;D) capabilities of its Merck Serono division by establishing a global R&amp;D center in Beijing, China. Merck is planning t<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[GSK and Nabi announce agreement for NicVAX, a vaccine for nicotine addiction]]></title>
<link>http://www.worldpharmanews.net/Corporate/GSK_and_Nabi_announce_agreement_for_NicVAX%AE_a_vaccine_for_nicotine_addiction/</link>
<comments>http://www.worldpharmanews.net/Corporate/GSK_and_Nabi_announce_agreement_for_NicVAX%AE_a_vaccine_for_nicotine_addiction/</comments>
<pubDate>Wed, 25 Nov 2009 00:30:41 EET</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/GSK_and_Nabi_announce_agreement_for_NicVAX%AE_a_vaccine_for_nicotine_addiction/</guid>
<description><![CDATA[GlaxoSmithKline Biologicals SA (GSK) and Nabi Biopharmaceuticals (Nabi) announcedan exclusive worldwide option and licensing agreement for a nicotine conjugate candidate vaccine (NicVAX®), an investi<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain]]></title>
<link>http://www.worldpharmanews.net/Corporate/Abbott_to_Acquire_Novel_Investigational_Biologic_to_Treat_Chronic_Pain/</link>
<comments>http://www.worldpharmanews.net/Corporate/Abbott_to_Acquire_Novel_Investigational_Biologic_to_Treat_Chronic_Pain/</comments>
<pubDate>Mon, 16 Nov 2009 02:53:08 EET</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Abbott_to_Acquire_Novel_Investigational_Biologic_to_Treat_Chronic_Pain/</guid>
<description><![CDATA[Abbott (NYSE: ABT) announced a definitive agreement to acquire the global rights to PanGenetics BV's PG110 fully humanized antibody to Nerve Growth Factor (NGF), expanding the company's pain care p<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Abbott Completes Visiogen Acquisition]]></title>
<link>http://www.worldpharmanews.net/Corporate/Abbott_Completes_Visiogen_Acquisition/</link>
<comments>http://www.worldpharmanews.net/Corporate/Abbott_Completes_Visiogen_Acquisition/</comments>
<pubDate>Fri, 30 Oct 2009 23:46:29 EET</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Abbott_Completes_Visiogen_Acquisition/</guid>
<description><![CDATA[Abbott (NYSE: ABT) has completed its acquisition of privately held eye care company Visiogen, expanding the company's vision care business with a next-generation accommodating intraocular lens (IOL)<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Pfizer And Wyeth Become One: Working Together For A Healthier Worlda4]]></title>
<link>http://www.worldpharmanews.net/Corporate/Pfizer_And_Wyeth_Become_One_Working_Together_For_A_Healthier_Worldtrade/</link>
<comments>http://www.worldpharmanews.net/Corporate/Pfizer_And_Wyeth_Become_One_Working_Together_For_A_Healthier_Worldtrade/</comments>
<pubDate>Tue, 20 Oct 2009 01:01:35 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Pfizer_And_Wyeth_Become_One_Working_Together_For_A_Healthier_Worldtrade/</guid>
<description><![CDATA[Pfizer Inc (NYSE: PFE) today announced that it has combined operations with Wyeth following the closing of the acquisition yesterday. Pfizer is now a more diversified health care company, with produc<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Pfizer and Wyeth to Divest Certain Animal Health Assets to Boehringer Ingelheim]]></title>
<link>http://www.worldpharmanews.net/Corporate/Pfizer_and_Wyeth_to_Divest_Certain_Animal_Health_Assets_to_Boehringer_Ingelheim/</link>
<comments>http://www.worldpharmanews.net/Corporate/Pfizer_and_Wyeth_to_Divest_Certain_Animal_Health_Assets_to_Boehringer_Ingelheim/</comments>
<pubDate>Tue, 22 Sep 2009 02:13:24 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Pfizer_and_Wyeth_to_Divest_Certain_Animal_Health_Assets_to_Boehringer_Ingelheim/</guid>
<description><![CDATA[Pfizer Inc (NYSE: PFE) and Wyeth (NYSE: WYE) announced that they have entered into an agreement with Boehringer Ingelheim to divest certain animal health assets in connection with the regulatory appr<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Lilly Unveils Blueprint for Speeding Innovative Medicines to Patients]]></title>
<link>http://www.worldpharmanews.net/Corporate/Lilly_Unveils_Blueprint_for_Speeding_Innovative_Medicines_to_Patients/</link>
<comments>http://www.worldpharmanews.net/Corporate/Lilly_Unveils_Blueprint_for_Speeding_Innovative_Medicines_to_Patients/</comments>
<pubDate>Wed, 16 Sep 2009 01:54:40 EEST</pubDate>
<dc:creator>PharmaNewsEU</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Lilly_Unveils_Blueprint_for_Speeding_Innovative_Medicines_to_Patients/</guid>
<description><![CDATA[Eli Lilly and Company (NYSE: LLY) has unveiled a new operating model and announced a series of changes to speed medicines from its pipeline to patients. To help achieve this goal, the company will es<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Roche recognised as new Super Sector Leader in Dow Jones Sustainability Index]]></title>
<link>http://www.worldpharmanews.net/Corporate/Roche_recognised_as_new_Super_Sector_Leader_in_Dow_Jones_Sustainability_Index/</link>
<comments>http://www.worldpharmanews.net/Corporate/Roche_recognised_as_new_Super_Sector_Leader_in_Dow_Jones_Sustainability_Index/</comments>
<pubDate>Sat, 05 Sep 2009 23:54:03 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Roche_recognised_as_new_Super_Sector_Leader_in_Dow_Jones_Sustainability_Index/</guid>
<description><![CDATA[Roche (SIX: RO, ROG; OTCQX: RHHBY) has been rated as the new Super Sector Leader in Healthcare on the Dow Jones Sustainability Index, placing Roche as the most sustainable healthcare company worldwid<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test]]></title>
<link>http://www.worldpharmanews.net/Corporate/Abbott_to_Collaborate_With_Pfizer_Inc_on_Companion_Diagnostic_Test/</link>
<comments>http://www.worldpharmanews.net/Corporate/Abbott_to_Collaborate_With_Pfizer_Inc_on_Companion_Diagnostic_Test/</comments>
<pubDate>Mon, 31 Aug 2009 00:13:02 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Abbott_to_Collaborate_With_Pfizer_Inc_on_Companion_Diagnostic_Test/</guid>
<description><![CDATA[Abbott has entered into an agreement with Pfizer Inc to develop a molecular diagnostic test intended to screen non-small cell lung cancer (NSCLC) tumors for the presence of gene rearrangements. Pfize<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Imexpharma are specialized in helping pharmaceutical companies to enter and attain success in Kazakhstan.]]></title>
<link>http://www.worldpharmanews.net/Corporate/Imexpharma_are_specialized_in_helping_pharmaceutical_companies_to_enter_and_attain_success_in_Kazakhstan-/</link>
<comments>http://www.worldpharmanews.net/Corporate/Imexpharma_are_specialized_in_helping_pharmaceutical_companies_to_enter_and_attain_success_in_Kazakhstan-/</comments>
<pubDate>Mon, 31 Aug 2009 00:12:51 EEST</pubDate>
<dc:creator>Imexpharma</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Imexpharma_are_specialized_in_helping_pharmaceutical_companies_to_enter_and_attain_success_in_Kazakhstan-/</guid>
<description><![CDATA[IMEXPHARMA is a global pharmaceutical distributor with extensive experience distributing pharmaceutical product in Kazakhstan.<br/><br/>5 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Pfizer And Private Access Announce Plans To Develop Online Community To Accelerate Clinical Research]]></title>
<link>http://www.worldpharmanews.net/Corporate/Pfizer_And_Private_Access_Announce_Plans_To_Develop_Online_Community_To_Accelerate_Clinical_Research/</link>
<comments>http://www.worldpharmanews.net/Corporate/Pfizer_And_Private_Access_Announce_Plans_To_Develop_Online_Community_To_Accelerate_Clinical_Research/</comments>
<pubDate>Mon, 24 Aug 2009 10:05:36 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Pfizer_And_Private_Access_Announce_Plans_To_Develop_Online_Community_To_Accelerate_Clinical_Research/</guid>
<description><![CDATA[Recognizing that patient participation in clinical trials is the key to progress in medical research, Pfizer Inc has entered into a collaboration with Private Access, the innovator in privacy-enhance<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[a4Antiquateda4 systems means the Government is not delivering]]></title>
<link>http://www.worldpharmanews.net/Corporate/lsquoAntiquatedrsquo_systems_means_the_Government_is_not_delivering-1/</link>
<comments>http://www.worldpharmanews.net/Corporate/lsquoAntiquatedrsquo_systems_means_the_Government_is_not_delivering-1/</comments>
<pubDate>Wed, 12 Aug 2009 01:20:40 EEST</pubDate>
<dc:creator>GDSInternational</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/lsquoAntiquatedrsquo_systems_means_the_Government_is_not_delivering-1/</guid>
<description><![CDATA[Claims the Commissioner of the Chicago Department of Public Health during an exclusive interview for MeettheBoss.comDr. Terry Mason, Commissioner for Chicago's Department of Public Health (CDPH),<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[President Clinton, Pfizer, and Mylan Announce New Agreements to Lower Prices of Medicines]]></title>
<link>http://www.worldpharmanews.net/Corporate/President_Clinton_Pfizer_and_Mylan_Announce_New_Agreements_to_Lower_Prices_of_Medicines/</link>
<comments>http://www.worldpharmanews.net/Corporate/President_Clinton_Pfizer_and_Mylan_Announce_New_Agreements_to_Lower_Prices_of_Medicines/</comments>
<pubDate>Mon, 10 Aug 2009 01:01:58 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/President_Clinton_Pfizer_and_Mylan_Announce_New_Agreements_to_Lower_Prices_of_Medicines/</guid>
<description><![CDATA[President Bill Clinton announced two important and complementary agreements today to enable better, more affordable treatments for patients on second-line antiretroviral (ARV) therapy for HIV/AIDS in<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Amgen to collaborate with GSK to commercialize denosumab in Europe for postmenopausal osteoporosis]]></title>
<link>http://www.worldpharmanews.net/Corporate/Amgen_to_collaborate_with_GSK_to_commercialize_denosumab_in_Europe_for_postmenopausal_osteoporosis/</link>
<comments>http://www.worldpharmanews.net/Corporate/Amgen_to_collaborate_with_GSK_to_commercialize_denosumab_in_Europe_for_postmenopausal_osteoporosis/</comments>
<pubDate>Thu, 30 Jul 2009 01:10:34 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Amgen_to_collaborate_with_GSK_to_commercialize_denosumab_in_Europe_for_postmenopausal_osteoporosis/</guid>
<description><![CDATA[Amgen (NASDAQ:AMGN) and GlaxoSmithKline (GSK) announced a collaboration in which the companies will share commercialization of Amgen's monoclonal antibody denosumab for postmenopausal osteoporosis (<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[WHO grants prequalification to Cervarix: GSK's vaccine to help combat cervical cancer in developing nations]]></title>
<link>http://www.worldpharmanews.net/Corporate/WHO_grants_prequalification_to_Cervarix%AE_GSKs_vaccine_to_help_combat_cervical_cancer_in_developing_nations/</link>
<comments>http://www.worldpharmanews.net/Corporate/WHO_grants_prequalification_to_Cervarix%AE_GSKs_vaccine_to_help_combat_cervical_cancer_in_developing_nations/</comments>
<pubDate>Tue, 14 Jul 2009 22:12:32 EEST</pubDate>
<dc:creator>PharmaNewsEU</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/WHO_grants_prequalification_to_Cervarix%AE_GSKs_vaccine_to_help_combat_cervical_cancer_in_developing_nations/</guid>
<description><![CDATA[The World Health Organization (WHO) has awarded prequalification to Cervarix®, GlaxoSmithKline's cervical cancer vaccine. The WHO decision is necessary for UN agencies and the GAVI Alliance to purch<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Lundbeck strengthens its research capabilities by acquiring ground-breaking Danish technologies]]></title>
<link>http://www.worldpharmanews.net/Corporate/Lundbeck_strengthens_its_research_capabilities_by_acquiring_ground-breaking_Danish_technologies/</link>
<comments>http://www.worldpharmanews.net/Corporate/Lundbeck_strengthens_its_research_capabilities_by_acquiring_ground-breaking_Danish_technologies/</comments>
<pubDate>Wed, 08 Jul 2009 10:15:27 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Lundbeck_strengthens_its_research_capabilities_by_acquiring_ground-breaking_Danish_technologies/</guid>
<description><![CDATA[Through the acquisition of the Aarhus-based biotech company NeuronIcon, Lundbeck will gain ownership of technologies that may lead to a breakthrough in the treatment of brain damage following strokes<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer]]></title>
<link>http://www.worldpharmanews.net/Corporate/Graceway_Pharmaceuticals_Acquires_Early-stage_Dermatological_Molecules_from_Pfizer/</link>
<comments>http://www.worldpharmanews.net/Corporate/Graceway_Pharmaceuticals_Acquires_Early-stage_Dermatological_Molecules_from_Pfizer/</comments>
<pubDate>Tue, 07 Jul 2009 00:07:33 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Graceway_Pharmaceuticals_Acquires_Early-stage_Dermatological_Molecules_from_Pfizer/</guid>
<description><![CDATA[Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, and Pfizer Inc. (NYSE: PFE) have entered into an Acquisition and License Agreement by which Graceway will acquire the wo<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration]]></title>
<link>http://www.worldpharmanews.net/Corporate/Boehringer_Ingelheim_and_Vitae_Pharmaceuticals_announce_a_major_collaboration/</link>
<comments>http://www.worldpharmanews.net/Corporate/Boehringer_Ingelheim_and_Vitae_Pharmaceuticals_announce_a_major_collaboration/</comments>
<pubDate>Thu, 18 Jun 2009 00:03:52 EEST</pubDate>
<dc:creator>PharmaNewsEU</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Boehringer_Ingelheim_and_Vitae_Pharmaceuticals_announce_a_major_collaboration/</guid>
<description><![CDATA[Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced today that they have entered into a significant worldwide collaboration to research and develop beta-secretase (BACE) inhibitors for th<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[GSK and Shenzhen Neptunus create new alliance to develop and manufacture influenza vaccines in China]]></title>
<link>http://www.worldpharmanews.net/Corporate/GSK_and_Shenzhen_Neptunus_create_new_alliance_to_develop_and_manufacture_influenza_vaccines_in_China/</link>
<comments>http://www.worldpharmanews.net/Corporate/GSK_and_Shenzhen_Neptunus_create_new_alliance_to_develop_and_manufacture_influenza_vaccines_in_China/</comments>
<pubDate>Thu, 11 Jun 2009 21:08:35 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/GSK_and_Shenzhen_Neptunus_create_new_alliance_to_develop_and_manufacture_influenza_vaccines_in_China/</guid>
<description><![CDATA[GlaxoSmithKline plc (GSK) has entered into a definitive agreement to form a new Joint Venture with Shenzhen Neptunus Interlong Bio-Technique Co. Ltd (Shenzhen Neptunus) focused on developing and manu<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Sanofi-aventis to strengthen Insulin Production Capacities]]></title>
<link>http://www.worldpharmanews.net/Corporate/Sanofi-aventis_to_strengthen_Insulin_Production_Capacities/</link>
<comments>http://www.worldpharmanews.net/Corporate/Sanofi-aventis_to_strengthen_Insulin_Production_Capacities/</comments>
<pubDate>Thu, 11 Jun 2009 21:08:24 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Sanofi-aventis_to_strengthen_Insulin_Production_Capacities/</guid>
<description><![CDATA[Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that Sanofi-Aventis Deutschland GmbH has purchased from Pfizer the Diabel manufacturing plant in Frankfurt-Höchst, Germany, one of the largest s<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[World Health Organization grants Global Prequalification to GSK's Rotarix vaccine]]></title>
<link>http://www.worldpharmanews.net/Corporate/World_Health_Organization_grants_Global_Prequalification_to_GSKs_Rotarix%C2%99_vaccine/</link>
<comments>http://www.worldpharmanews.net/Corporate/World_Health_Organization_grants_Global_Prequalification_to_GSKs_Rotarix%C2%99_vaccine/</comments>
<pubDate>Tue, 09 Jun 2009 00:26:35 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/World_Health_Organization_grants_Global_Prequalification_to_GSKs_Rotarix%C2%99_vaccine/</guid>
<description><![CDATA[The World Health Organisation (WHO) has awarded global prequalification to GlaxoSmithKline Biologicals' vaccine against rotavirus, Rotarix™.Additionally, the WHO's Strategic Advisory Group of Exper<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[AstraZeneca and Abbott Extend Relationship to Include Co-Promotion of Trilipix]]></title>
<link>http://www.worldpharmanews.net/Corporate/AstraZeneca_and_Abbott_Extend_Relationship_to_Include_Co-Promotion_of_Trilipix/</link>
<comments>http://www.worldpharmanews.net/Corporate/AstraZeneca_and_Abbott_Extend_Relationship_to_Include_Co-Promotion_of_Trilipix/</comments>
<pubDate>Mon, 08 Jun 2009 00:21:24 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/AstraZeneca_and_Abbott_Extend_Relationship_to_Include_Co-Promotion_of_Trilipix/</guid>
<description><![CDATA[AstraZeneca and Abbott have entered into an agreement for AstraZeneca to co-promote Abbott's TRILIPIX, a medication for use alone or in combination with a statin to treat certain lipid disorders. Un<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Genzyme Completes Transaction with Bayer HealthCare]]></title>
<link>http://www.worldpharmanews.net/Corporate/Genzyme_Completes_Transaction_with_Bayer_HealthCare/</link>
<comments>http://www.worldpharmanews.net/Corporate/Genzyme_Completes_Transaction_with_Bayer_HealthCare/</comments>
<pubDate>Thu, 04 Jun 2009 00:07:20 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Genzyme_Completes_Transaction_with_Bayer_HealthCare/</guid>
<description><![CDATA[Genzyme Corp. (Nasdaq: GENZ) has completed the transaction with Bayer HealthCare to acquire the worldwide rights to Campath®/MabCampath® (alemtuzumab), giving Genzyme primary responsibility for the d<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[GlaxoSmithKline update: A (H1N1) influenza vaccine development]]></title>
<link>http://www.worldpharmanews.net/Corporate/GlaxoSmithKline_update_A_H1N1_influenza_vaccine_development/</link>
<comments>http://www.worldpharmanews.net/Corporate/GlaxoSmithKline_update_A_H1N1_influenza_vaccine_development/</comments>
<pubDate>Thu, 21 May 2009 00:54:29 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/GlaxoSmithKline_update_A_H1N1_influenza_vaccine_development/</guid>
<description><![CDATA[GSK is committed to supporting governments and health authorities around the world to respond to the emergence of the new A (H1N1) influenza strain. Since the outbreak, the company has been in contin<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Pfizer Launches Free Medicines Program For Newly Unemployed Americans]]></title>
<link>http://www.worldpharmanews.net/Corporate/Pfizer_Launches_Free_Medicines_Program_For_Newly_Unemployed_Americans/</link>
<comments>http://www.worldpharmanews.net/Corporate/Pfizer_Launches_Free_Medicines_Program_For_Newly_Unemployed_Americans/</comments>
<pubDate>Sat, 16 May 2009 19:29:49 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Pfizer_Launches_Free_Medicines_Program_For_Newly_Unemployed_Americans/</guid>
<description><![CDATA[Pfizer Inc will launch an innovative program to help eligible unemployed Americans and their families who have lost their health insurance maintain access to their Pfizer medicines for free. The insp<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Roche provides additional donation of 5.65 million packs of Tamiflu to WHO]]></title>
<link>http://www.worldpharmanews.net/Corporate/Roche_provides_additional_donation_of_5-65_million_packs_of_Tamiflu_to_WHO/</link>
<comments>http://www.worldpharmanews.net/Corporate/Roche_provides_additional_donation_of_5-65_million_packs_of_Tamiflu_to_WHO/</comments>
<pubDate>Fri, 15 May 2009 00:22:56 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Roche_provides_additional_donation_of_5-65_million_packs_of_Tamiflu_to_WHO/</guid>
<description><![CDATA[Roche has announced a new donation to the World Health Organization (WHO) of 5.65 million courses of treatment of the antiviral drug Tamiflu (oseltamivir). This donation includes:<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[XStream's XT250 Verifies WHO Counterfeit Drug Figure for US Rx Supply  Chain]]></title>
<link>http://www.worldpharmanews.net/Corporate/XStreams_XT250_Verifies_WHO_Counterfeit_Drug_Figure_for_US_Rx_Supply__Chain-1/</link>
<comments>http://www.worldpharmanews.net/Corporate/XStreams_XT250_Verifies_WHO_Counterfeit_Drug_Figure_for_US_Rx_Supply__Chain-1/</comments>
<pubDate>Sat, 09 May 2009 14:16:00 EEST</pubDate>
<dc:creator>RosieAdams</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/XStreams_XT250_Verifies_WHO_Counterfeit_Drug_Figure_for_US_Rx_Supply__Chain-1/</guid>
<description><![CDATA[Based on their usage data from end user XT250 systems, XStream Systems can verify the accuracy of the World Health Organization's (WHO) estimate of 1% counterfeits in the United States pharmaceutical<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Bayer and Ardea Biosciences Enter Global Agreement Focused on the Development of MEK Inhibitors]]></title>
<link>http://www.worldpharmanews.net/Corporate/Bayer_and_Ardea_Biosciences_Enter_Global_Agreement_Focused_on_the_Development_of_MEK_Inhibitors/</link>
<comments>http://www.worldpharmanews.net/Corporate/Bayer_and_Ardea_Biosciences_Enter_Global_Agreement_Focused_on_the_Development_of_MEK_Inhibitors/</comments>
<pubDate>Fri, 01 May 2009 00:28:38 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Bayer_and_Ardea_Biosciences_Enter_Global_Agreement_Focused_on_the_Development_of_MEK_Inhibitors/</guid>
<description><![CDATA[Bayer HealthCare AG, Germany has entered into a global agreement with Ardea Biosciences, Inc., San Diego California, USA (Nasdaq: RDEA) focused on the development of small molecule mitogen-activated <br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Pfizer And University College London Announce Collaboration To Advance Development Of Stem Cell-Based Therapies]]></title>
<link>http://www.worldpharmanews.net/Corporate/Pfizer_And_University_College_London_Announce_Collaboration_To_Advance_Development_Of_Stem_Cell-Based_Therapies/</link>
<comments>http://www.worldpharmanews.net/Corporate/Pfizer_And_University_College_London_Announce_Collaboration_To_Advance_Development_Of_Stem_Cell-Based_Therapies/</comments>
<pubDate>Sun, 26 Apr 2009 16:42:32 EEST</pubDate>
<dc:creator>PharmaNewsEU</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Pfizer_And_University_College_London_Announce_Collaboration_To_Advance_Development_Of_Stem_Cell-Based_Therapies/</guid>
<description><![CDATA[Pfizer Regenerative Medicine today announced that it has entered into a collaboration and license agreement with University College London focused on gaining better understanding into how to develop <br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[The First Pharmaceutical Company for Protection of Human Rights in Clinical Research]]></title>
<link>http://www.worldpharmanews.net/Corporate/The_First_Pharmaceutical_Company_for_Protection_of_Human_Rights_in_Clinical_Research/</link>
<comments>http://www.worldpharmanews.net/Corporate/The_First_Pharmaceutical_Company_for_Protection_of_Human_Rights_in_Clinical_Research/</comments>
<pubDate>Wed, 08 Apr 2009 00:40:15 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/The_First_Pharmaceutical_Company_for_Protection_of_Human_Rights_in_Clinical_Research/</guid>
<description><![CDATA[Pfizer Inc announced has become the first pharmaceutical company to be accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP) for ensuring the protection o<br/><br/>3 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Pfizer Development Pipeline Shows Advances In High-Priority Disease Areas]]></title>
<link>http://www.worldpharmanews.net/Corporate/Pfizer_Development_Pipeline_Shows_Advances_In_High-Priority_Disease_Areas/</link>
<comments>http://www.worldpharmanews.net/Corporate/Pfizer_Development_Pipeline_Shows_Advances_In_High-Priority_Disease_Areas/</comments>
<pubDate>Sun, 05 Apr 2009 13:29:04 EEST</pubDate>
<dc:creator>PharmaNewsEU</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Pfizer_Development_Pipeline_Shows_Advances_In_High-Priority_Disease_Areas/</guid>
<description><![CDATA[Pfizer Inc has provided an update to its pipeline, highlighting the progression of clinical programs in high-priority therapeutic areas, and announced the start of Phase 3 clinical trials for two new<br/><br/>2 Vote(s) ]]></description>
</item>

</channel>
</rss>
